DMPK
MOLECULAR TARGETDM1 protein kinase
DMPK (DM1 protein kinase) is targeted by 21 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting DMPK
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | gefitinib | 5.67 | 290 |
| 2 | erlotinib | 5.55 | 256 |
| 3 | tofacitinib | 4.65 | 104 |
| 4 | alvocidib | 4.52 | 91 |
| 5 | ruxolitinib | 4.23 | 68 |
| 6 | bosutinib | 4.08 | 58 |
| 7 | bi 2536 | 4.01 | 54 |
| 8 | midostaurin | 3.85 | 46 |
| 9 | canertinib | 3.53 | 33 |
| 10 | pelitinib | 3.50 | 32 |
| 11 | tae 684 | 3.43 | 30 |
| 12 | fedratinib | 3.40 | 29 |
| 13 | at 7519 | 3.33 | 27 |
| 14 | jnj 7706621 | 3.09 | 21 |
| 15 | lestaurtinib | 3.04 | 20 |
| 16 | ruboxistaurin | 2.94 | 18 |
| 17 | kw 2449 | 2.64 | 13 |
| 18 | enzastaurin | 2.08 | 7 |
| 19 | rg 547 | 2.08 | 7 |
| 20 | Crizotinib | 0.69 | 1 |
| 21 | Dasatinib | 0.69 | 1 |
About DMPK as a Drug Target
DMPK (DM1 protein kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 21 compounds with documented DMPK interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
DMPK inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.